Arcus Biosciences, Inc.

NYSE:RCUS

16.46 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016
Revenue 117112382.88277.517158.3531.4130
Cost of Revenue 16147.05715978.48149.6462.6121.314
Gross Profit 10198375.825-81.483-63.481-41.293-1.199-1.314
Gross Profit Ratio 0.8630.8750.982-1.051-4.232-4.943-0.8490
Reseach & Development Expenses 340288256.348159.34878.48149.64647.21814.247
General & Administrative Expenses 11710472.28642.40425.22813.5667.6363.935
Selling & Marketing Expenses 170000000
SG&A 11710472.28642.40425.22813.5667.6363.935
Other Expenses -3400000000
Operating Expenses 457392328.634201.752103.70963.21254.85418.182
Operating Income -340-28054.248-124.235-88.709-54.859-53.441-18.182
Operating Income Ratio -2.906-2.50.142-1.603-5.914-6.568-37.8210
Total Other Income Expenses Net 39140.3971.3773.9990.3430.3590.212
Income Before Tax -301-26654.645-122.858-84.71-49.594-53.082-17.97
Income Before Tax Ratio -2.573-2.3750.143-1.585-5.647-5.937-37.5670
Income Tax Expense 611.815-6.181-8.7795.26500
Net Income -307-26753-116.677-75.931-49.594-53.082-17.97
Net Income Ratio -2.624-2.3840.138-1.505-5.062-5.937-37.5670
EPS -4.15-3.710.76-2.13-1.73-1.43-1.25-0.73
EPS Diluted -4.15-3.710.71-2.13-1.73-1.43-1.25-0.73
EBITDA -291-26454.905-124.848-88.709-56.088-50.829-16.868
EBITDA Ratio -2.487-2.3570.143-1.611-5.914-6.715-35.9720